Face Cream Derived From Human Umbilical Stem Cells Aimed At U.S. Market
This article was originally published in The Rose Sheet
Executive Summary
An agreement between soon-to-merge South Korean firm Histostem and Tampa, Fla.-based Stem Cell Therapy International is expected to deliver a skin-care product derived from human umbilical cord stem cells to the U.S. market in January